Location: Home / Volume 4, Part 1: Question 1
Part 1: Current Approach to Treating Chronic Myeloid Leukemia
Jack W. Erter, III, MD, and Ramiro Garzon, MD
Drs. Erter and Garzon are fellows; both are at the Division of Hematology/Oncology, Comprehensive Care Center, Ohio State University, Columbus, OH.
Question 1
Which of the following is not an indication for allogeneic hematopoietic stem cell transplantation (HSCT) in patients with chronic myeloid leukemia (CML) in the chronic phase?
